Selection criteria
We included all women patients undergoing MVR at our center from January
2010 to February 2020. We also included patients who underwent MVR with
atrial fibrillation (AF) ablation and tricuspid valve repair or
replacement. Age, sinus rhythm, and lifestyle were considered as a
recommendation for MBP. Women who desired to become pregnant, for whom
oral anticoagulants were contraindicated, and who showed poor
anticoagulant compliance were also considered for MBP, even if they were
< 60 years old. Our exclusion criteria were infective
endocarditis, prior cardiac operation, cardiogenic shock, emergency
operation, and concomitant coronary artery bypass graft or aortic valve
replacement. All patients with MBP received oral acetylsalicylic
acid at 150 mg daily only for the first 3-6months, while those
with MMP +/- AF regularly received daily oral anticoagulants such
as coumadin (warfarin®, Bristol-Myers Squibb, Egypt).